We don't know whether the most recent response to this request contains information or not – if you are Jamie campbell please sign in and let everyone know.

Base sequence

Jamie campbell made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

We're waiting for Jamie campbell to read recent responses and update the status.

Dear Medicines and Healthcare Products Regulatory Agency,

Can you kindly provide the full nucleotide base sequence for the mRNA used in both the Pfizer and Moderna COVID vaccines?

Yours faithfully,

Jamie Campbell

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 21/926
       
Dear Jamie Campbell,
       
RE:  REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
        
Thank you for your enquiry which we received on 16th August 2021.
  
I confirm that your request is now being handled under the Freedom of Information Act and you should receive a reply within 20 working days from our date of receipt. 
 
If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...
        
Kind Regards,

 
MHRA Customer Service Centre
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

FOI 21/926

 

Dear Jamie Campbell,

 

Thank you for your email.

 

Regarding your request, dated 15^th August 2021, for supporting
documentation for full nucleotide base sequence for the mRNA used in both
the Pfizer and Moderna COVID vaccines and full nucleotide base sequence
used in the recombinant DNA of the Oxford-AstraZeneca and Johnson and
Johnson vaccines is exempt under Section 41 (Information provided in
confidence) and Section 43 (Commercial interests) of the Freedom of
Information (FOI) Act.

 

Section 41 is an absolute exemption and no consideration of the public
interest is required, except to state that we consider its disclosure to
constitute an actionable breach of confidence.

 

Section 43 is a qualified exemption and a consideration of the public
interest should be made. We have considered the public interest and cannot
see any public interest argument that outweighs the commercial harm in
providing commercial secrets to competitors, who would be able to use this
information to aid the development of their own rival product.

 

If you disagree with how we have interpreted the Freedom of Information
Act 2000 with regards to your request, you can ask for the decision to be
reviewed. The review will be carried out by a senior member of the Agency
who was not involved with the original decision.

 

If you have a query about the information provided, please reply to this
email

 

If you are dissatisfied with the handling of your request, you have the
right to ask for an internal review. Internal review requests should be
submitted within two months of the date you receive this response and
addressed to: [1][MHRA request email]

 

Due to the ongoing Covid-19 situation, we are not able to accept delivery
of any documents or correspondence by post or courier to any of our
offices

 

Please remember to quote the reference number above in any future
communications.

 

If you were to remain dissatisfied with the outcome of the internal
review, you would have the right to apply directly to the Information
Commissioner for a decision. Please bear in mind that the Information
Commissioner will not normally review our handling of your request unless
you have first contacted us to conduct an internal review. The Information
Commissioner can be contacted at:

 

Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

Yours sincerely

 

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

 

 

 

show quoted sections

Dear MHRA Customer Services,

Why can I not get the information requested ?

1. The vaccine companies all have patents on the vaccines so they're protected.
2. If it's about health then who cares if other manufactures find out the sequence as that means more vaccines to save lives
3. Why are you recommending we inject chemicals you will not tell us full details on?

It is clearly about money, not health and it is obviously not safe for humans if you're hiding it.

SHAME ON YOU

Yours sincerely,

Jamie campbell

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

 

• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 

 

Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 

 

The UK has left the EU, and the transition period ends on 31 December
2020. Our [1]guidance and information can be accessed here. 

References

Visible links
1. https://www.gov.uk/government/collection...

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Internal Review of FOI 21/926
 
Dear Jamie Campbell,
 
Thank you for your email.
 
We confirm that an internal review will be carried out on FOI 21/926. We normally aim to respond to requests for internal review within 20 working days of receipt. However, due to high volumes of queries we are currently receiving related to COVID-19 please be aware that responses may take longer than usual.
 
Kind Regards
 
 
MHRA Customer Service Centre
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

2 Attachments

Internal Review of FOI 21/926

 

Dear Mr Campbell,

 

We have completed our Internal Review (IR) and are pleased to be able to
provide you with the nucleotide sequences for three out of four COVID-19
vaccines.

 

The original response applied the exemptions based on the general context
of the request i.e. a request for active substance data. Data on the
active substance/s are commonly exempted under Sections 41, and 43 of the
FOIA, as this is the portion of the dossier which contains the majority of
commercially sensitive information/information that would be valuable to
competitors. FOI requests should still also be considered on a
case-by-case basis; however, likely to resource constraints on this
occasion this did not occur and for this we apologise.

 

Having recommenced the FOI process with regard to your request we have
reconsidered the use of exemptions and hence provide you with the
attached. Please note, as part of the IR process we took an additional
step to contact the relevant companies, who then confirmed that release of
the attached documentation was acceptable.

 

Please note that we are still in discussions with the Moderna regarding
the release of the nucleotide sequence for COVID-19 vaccine Modena.

 

We will remind staff handling FOI requests of the need to consider the
specific request in context rather than reaching a decision to withhold
due to a discrete type of information.

 

Thank you for your patience whilst our response was awaited.

 

If you remain dissatisfied, you may ask the ICO to make a decision on
whether or not we have interpreted the FOIA correctly in dealing with the
request and subsequent internal review. The ICO’s address is:

The Information Commissioner’s Office

Wycliffe House

Water Lane

Wilmslow

Cheshire

SK9 5AF

 

Yours sincerely,

 

 

 

 

MHRA Customer Service Centre

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 0203 080 6000

 

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are Jamie campbell please sign in and let everyone know.